Shannon R. Morris, M.D., Ph.D., is a distinguished medical professional who currently holds the position of Chief Medical Officer at ERASCA INC, a leading biopharmaceutical company focused on developing innovative cancer therapies. Dr. Morris brings a wealth of experience and expertise to her role, having earned both her medical degree and doctorate in pharmacology from prestigious institutions. Her academic background, combined with her extensive clinical and research experience, has positioned her as a key leader in the field of oncology. Throughout her career, Dr. Morris has made significant contributions to the advancement of cancer treatment. She has held various leadership positions in both academic and industry settings, where she has spearheaded numerous clinical trials and research initiatives aimed at developing novel therapeutic approaches for various types of cancer. Her work has been published in several high-impact scientific journals, and she has been recognized with multiple awards for her contributions to the field. At ERASCA INC, Dr. Morris plays a pivotal role in guiding the company's clinical development strategy and overseeing the execution of its oncology-focused pipeline. As Chief Medical Officer, Dr. Morris is responsible for ensuring that ERASCA INC's clinical programs are designed and implemented with the highest standards of safety and efficacy. She works closely with cross-functional teams to translate the company's scientific discoveries into meaningful treatments for patients. Her leadership and vision are instrumental in driving ERASCA INC's mission to transform the lives of cancer patients through the development of groundbreaking therapies.